These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
499 related items for PubMed ID: 12411305
1. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Yamada T, Yamazaki H, Yamane T, Yoshino M, Okuyama H, Tsuneto M, Kurino T, Hayashi S, Sakano S. Blood; 2003 Mar 15; 101(6):2227-34. PubMed ID: 12411305 [Abstract] [Full Text] [Related]
2. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP. J Bone Miner Res; 2005 Sep 15; 20(9):1659-68. PubMed ID: 16059637 [Abstract] [Full Text] [Related]
3. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H. J Immunol; 2003 Nov 15; 171(10):5130-9. PubMed ID: 14607912 [Abstract] [Full Text] [Related]
4. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T. J Bone Miner Res; 2000 Sep 15; 15(9):1766-75. PubMed ID: 10976996 [Abstract] [Full Text] [Related]
5. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. J Bone Miner Res; 2000 Aug 15; 15(8):1459-66. PubMed ID: 10934644 [Abstract] [Full Text] [Related]
6. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H. J Bone Miner Res; 2001 Nov 15; 16(11):2074-81. PubMed ID: 11697804 [Abstract] [Full Text] [Related]
7. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF. J Bone Miner Res; 2002 Jul 15; 17(7):1200-10. PubMed ID: 12096833 [Abstract] [Full Text] [Related]
9. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. Khapli SM, Mangashetti LS, Yogesha SD, Wani MR. J Immunol; 2003 Jul 01; 171(1):142-51. PubMed ID: 12816992 [Abstract] [Full Text] [Related]
10. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H, Guo J, Bringhurst FR. J Bone Miner Res; 2002 Sep 01; 17(9):1667-79. PubMed ID: 12211438 [Abstract] [Full Text] [Related]
11. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. Bone; 1999 Nov 01; 25(5):517-23. PubMed ID: 10574571 [Abstract] [Full Text] [Related]
12. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor. Yamada N, Tsujimura T, Ueda H, Hayashi S, Ohyama H, Okamura H, Terada N. Cytokine; 2005 Aug 21; 31(4):288-97. PubMed ID: 15996478 [Abstract] [Full Text] [Related]
13. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. Proc Natl Acad Sci U S A; 1998 Mar 31; 95(7):3597-602. PubMed ID: 9520411 [Abstract] [Full Text] [Related]
14. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL. Endocrinology; 2000 Dec 31; 141(12):4768-76. PubMed ID: 11108292 [Abstract] [Full Text] [Related]
15. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T. J Biol Chem; 2003 Jun 27; 278(26):23971-7. PubMed ID: 12697767 [Abstract] [Full Text] [Related]
16. Bifurcation of osteoclasts and dendritic cells from common progenitors. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T. Blood; 2001 Oct 15; 98(8):2544-54. PubMed ID: 11588053 [Abstract] [Full Text] [Related]
18. FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function. Lean JM, Fuller K, Chambers TJ. Blood; 2001 Nov 01; 98(9):2707-13. PubMed ID: 11675341 [Abstract] [Full Text] [Related]